Myles Minter
Stock Analyst at William Blair
(4.96)
# 105
Out of 4,504 analysts
554
Total ratings
63.2%
Success rate
36.2%
Average return
Main Sectors:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintained: Buy | n/a | $58.25 | - | 49 | Jul 9, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | n/a | $485.39 | - | 32 | Jul 7, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | n/a | $6.97 | - | 21 | Jul 2, 2026 | |
| VTGN Vistagen Therapeutics | Maintained: Hold | n/a | $0.258 | - | 11 | Jun 30, 2026 | |
| LRMR Larimar Therapeutics | Reiterated: Buy | n/a | $4.28 | - | 19 | Jun 29, 2026 | |
| MRNA Moderna | Reiterated: Hold | n/a | $68.27 | - | 27 | Jun 27, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | n/a | $4.33 | - | 10 | Jun 25, 2026 | |
| ARGX argenx SE | Maintained: Buy | n/a | $877.62 | - | 19 | Jun 24, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | n/a | $14.22 | - | 17 | Jun 15, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | n/a | $1.68 | - | 14 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.09 | - | 25 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $97.60 | - | 20 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $233.80 | - | 63 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $177.11 | - | 31 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $15.55 | - | 11 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $85.89 | - | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $199.15 | - | 29 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.68 | - | 13 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.56 | - | 11 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.77 | - | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.48 | - | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.52 | - | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 | $68.92 | +17.02% | 14 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.61 | - | 11 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.92 | - | 12 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $14 | $15.19 | -7.83% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $298.76 | - | 16 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.38 | - | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.28 | n/a | 3 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.54 | n/a | 3 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $324.99 | n/a | 5 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.72 | n/a | 15 | Dec 29, 2022 |
Ionis Pharmaceuticals
Jul 9, 2026
Maintained: Buy
Price Target: n/a
Current: $58.25
Upside: -
Vertex Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: n/a
Current: $485.39
Upside: -
Arcturus Therapeutics Holdings
Jul 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.97
Upside: -
Vistagen Therapeutics
Jun 30, 2026
Maintained: Hold
Price Target: n/a
Current: $0.258
Upside: -
Larimar Therapeutics
Jun 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.28
Upside: -
Moderna
Jun 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $68.27
Upside: -
Camp4 Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.33
Upside: -
argenx SE
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $877.62
Upside: -
Intellia Therapeutics
Jun 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.22
Upside: -
Neumora Therapeutics
Jun 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.68
Upside: -
Jun 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.09
Upside: -
Jun 10, 2026
Maintained: Buy
Price Target: n/a
Current: $97.60
Upside: -
Jun 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $233.80
Upside: -
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $177.11
Upside: -
May 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $15.55
Upside: -
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $85.89
Upside: -
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $199.15
Upside: -
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $25.68
Upside: -
May 18, 2026
Maintained: Buy
Price Target: n/a
Current: $14.56
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.77
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.48
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $2.52
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $81
Current: $68.92
Upside: +17.02%
May 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.61
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $6.92
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $13 → $14
Current: $15.19
Upside: -7.83%
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $298.76
Upside: -
Mar 31, 2026
Maintained: Buy
Price Target: n/a
Current: $12.38
Upside: -
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $4.28
Upside: n/a
Sep 28, 2023
Maintained: Buy
Price Target: n/a
Current: $3.54
Upside: n/a
Mar 3, 2023
Downgraded: Hold
Price Target: n/a
Current: $324.99
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $4.72
Upside: n/a